, Volume 36, Supplement 1, pp S45–S47 | Cite as

In vivo measurement of the redox state



As part of an aerobic life, we oxidize a large pool of biomolecules to obtain chemical energy. During this process, several intermediates are formed; some are chemically unstable and are referred to as free radicals (FR). FR tend to react quickly with their surrounding biological environment; depending on the nature of the molecule attacked, different reactions can occur, i.e., lipid peroxidation, protein oxidation, or DNA oxidation products. As aerobic life has evolved, antioxidant defense systems against FR have developed. When an imbalance between production of FR (oxidants) and defese systems against them (antioxidants) happens, a situation of oxidative stress occurs. This can lead to irreversible biochemical changes, with subsequent tissue damage and disease. Establishing the involvement of FR in the pathogenesis of a disease has been difficult because of the lack of sensitie and specific methodology to detect them. No ideal biomarkers for in vivo FR-induced damage are available as yet. However, some reliable indices of FR formation are now available, and in some pathologic conditions, evidence is accumulating to show that FR damage might play a functional role. The task for the near future will be to try to simplify the analytical methodology and elucidate the molecular mechanisms underlying the formation, disposition, and kinetics of FR marker molecules.



free radical


gas chromatography




high-performance liquid chromatography




lipid peroxidation




mass spectrometry








reactive oxygen species


thiobarbituric acid reacting substances


  1. 1.
    Halliwell, B. (1994) Free Radicals, Antioxidants, and Human Disease: Curiosity, Cause, or Consequence? Lancet 344, 721–724.PubMedCrossRefGoogle Scholar
  2. 2.
    Halliwell, B. (1999) Antioxidant Defense Mechanisms: From the Beginning to the End (of the Beginning), Free Radical Res. 31, 261–272.CrossRefGoogle Scholar
  3. 3.
    De Zwart, L.L., Meerman, J.H.N., Commandeur, J.N.N., and Veremeulen, N.P.E. (1999) Biomarkers of Free Radical Damage Application in Experimental Animals and in Humans, Free Radical Biol. Med. 26, 202–226.CrossRefGoogle Scholar
  4. 4.
    Moore, K., and Roberts, L.J. (1998). Measurement of Lipid Peroxidation, Free Radical Res. 28, 659–671.Google Scholar
  5. 5.
    Yeo, H.C., Helbock, H.J., Chyu, D.W., and Ames, B.N. (1994) Assay of Malondialdehyde in Biological Fluids by Gas Chromatography-Mass Spectrometry, Anal. Biochem. 220, 391–396.PubMedCrossRefGoogle Scholar
  6. 6.
    Selley, M.L. (1997) Determination of the Lipid Peroxidation Product 4-Hydroxy-2-nonenal in Clinical Samples by Gas Chromatography-Negative Ion Chemical Ionisation Mass Spectrometry of the O-Pentafluorobenzyl Oxime, J. Chromatogr. 691, 263–268.Google Scholar
  7. 7.
    Praticò, D. (1999) F2-Isoprostanes: Sensitive and Specific Noninvasive Indices of Lipid Peroxidation in vivo, Atherosclerosis 147, 1–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Cadet, J., D'Ham, C., Douki, T., Pouget, J.P., Ravanat, J.L., and Sauvaigo, S. (1998) Facts and Artifacts in the Measurement of Oxidative Base Damage to DNA, Free Radical Res. 29, 541–550.CrossRefGoogle Scholar
  9. 9.
    Senturker, S., and Dizdaroglu, M. (1999) The Effects of Experimental Conditions on the Levels of Oxidatively Modified Bases in DNA as Measured by Gas Chromatography-Mass Spectrometry. How Many Modified Bases Are Involved? Pre-purification or Not? Free Radical Biol. Med. 27, 370–380.CrossRefGoogle Scholar
  10. 10.
    Davies, M.J., Fu, S., Wang, H., and Dean, R.T. (1999) Stable Markers of Oxidant Damage to Proteins and Their Application in the Study of Human Disease, Free Radical Biol. Med 27, 1151–1163.CrossRefGoogle Scholar
  11. 11.
    Lyras, L., Evans, P., Shaw, P.J., Ince, P.G., and Halliwell, B. (1996) Oxidative Damage and Motor Neuron Disease Difficulties in the Measurement of Protein Carbonyl in Human Brain Tissue, Free Radical Res. 24, 397–406.Google Scholar

Copyright information

© AOCS Press 2001

Authors and Affiliations

  1. 1.Center for Experimental Therapeutics, Department of PharmacologyUniversity of PennsylvaniaPhiladelphia

Personalised recommendations